Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model

Hepatology

Volumn 29, Issue 3, 1999, Pages 746-755

  Trop, Shivti ^a   Samsonov, Dimitri ^a   Gotsman, Israel ^a   Alper, Ruslana ^a   Diment, Judith ^a   Ilan, Yaron ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN NK1 1; TRANSFORMING GROWTH FACTOR BETA1; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; IMMUNOLOGICAL TOLERANCE; LIVER ASSOCIATED LYMPHOCYTE; LIVER CELL; LYMPHOCYTE; LYMPHOCYTE DEPLETION; LYMPHOCYTOTOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033023853     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290334     Document Type: Article

References (19)

1. Weiner H. Oral tolerance. Proc Natl Acad Sci U S A 1994;91:10762-10765.
2. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997;18:335-343.
3. Miller A, Lider O, Roberts AB, Sporn M, Weiner HL. Suppressor T cells generated by oral tolerance to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGFβ following antigen specific triggering. Proc Natl Acad Sci U S A 1992;89:421-425.
4. Crispe N, Mehal WZ. Strange brew: T cells in the liver. Immun Today 1996;11:236-245.
5. Ilan Y, Roy Chowdhury N, Sauter B, Thummala NR, Horwitz MS, Davidson A, Nakamura J, et al. A critical role of the liver in inducing oral tolerance to adenoviral vectors for long term gene therapy. Castro 1998;114:260A.
6. Gallery MP, Kamei T, Flye W. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res 1989;46:391-394.
7. Nakano Y, Monden M, Valdivia LA, Gotoh M, Tono T, Mon T. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats. Surgery 1992;111:668-676.
8. Yu SY, Nakafusa Y, Flye MW. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsivenss and graft tolerance. Surgery 1994;116:229-234.
9. Garcia-Barcina M, Winnock M, Bidaurrazaga I, Huet S, Biolac Sage P, Balabaud C. Detection of cell adhesions molecules on human liver associated lymphocytes. Immunology 1994;82:95-8.
10. MacDonaland RH. NK1.1+ T cells receptor a/b + cells: new clues to their origin, specificity and function. J Exp Med 1995;182:633-638.
11. Bendelac A. Mouse NK1.1+ T cells. Curr Opin in Immunol 1995;7:367-374.
12. Takahashi M, Ogasawara K, Takeda K, Hashimoto W, Sakihara H, Kumagai K, Anzai R. LPS induces NK1. 1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol 1996;156:2436-2442.
13. Doherty DG, Morris S, Collins C, McEntee G, Traynor O, Hegarty J, O'Farrelly C. Human lymphocytes with dual T cell and natural killer cell phenotype and function in the normal adult liver. HEPATOLOGY 1997;26:445A.
14. Neurath M, Kelasall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med 1996;183:2605-2616.
15. Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Anderson CN, Bhan AK. Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 1996;183:847-856.
16. Strober W, Kelsall B, Fuss L, Marth T, Ludviksson B, Ehrhardt R, Neurath M. Reciprocal IFN-γ and TGF β responses regulate the occurrence of mucosal inflammation. Immunol Today 1997;18:61-64.
17. Ilan Y, Weksler-Zangen S, Ben-Horin S, Sestiere M, Diment J, Sauter B, Roy Chowdhury N, et al. Treatment of experimental colitis through induction of oral tolerance towards colitis extracted proteins. Gastroenterology 1998;114:4100A.
18. Ilan Y, Sauter B, Roy Chowdhury N, Prakash R, Reddy BVN, Sengupta K, Horwitz MS, et al. Effective adenovirus-mediated gene therapy in the presence of preexisting anti-adenovirus antibodies by oral tolerization of the host. HEPATOLOGY 1998;27:1368-1376.
19. Koo GC, Dumont FJ, Tutt M, Hackett J, Kumar V. The NK1.1-mouse: A model to study differentiation of murine NK cells. J Immunol 1988;137:3742-3747.